Home › Funds › Seven Fleet Capital Management LP › STRO
Seven Fleet Capital Management LP position in STRO
SUTRO BIOPHARMA INC · Health Care
Seven Fleet Capital Management LP reported holding 99,894 shares of STRO (SUTRO BIOPHARMA INC) in its Q3 2026 13F filing — a position valued at US$1.6M, representing 0.31% of its reported portfolio and ranking #38 among its reported holdings. Seven Fleet Capital Management LP has disclosed STRO holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Seven Fleet Capital Management LP's STRO position evolved
Seven Fleet Capital Management LP first disclosed a stake in STRO in Q2 2026 at 159,118 shares (US$3.8M). Across 2 filings, Seven Fleet Capital Management LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 99,894 shares valued at US$1.6M — a reduction of -59,224 shares quarter over quarter.. Notable position changes include a 37% trim in Q3 2026 (shares fell 42% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 159.12K | $3.79M | New |
| Q3 2026 | 99.89K | $1.61M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About STRO and 13F data
STRO (SUTRO BIOPHARMA INC) is a Health Care company. 35 other funds we track also report a position in STRO — the largest reported positions include BVF INC/IL (US$20.2M), Affinity Asset Advisors, LLC (US$18.6M), Samsara BioCapital, LLC (US$17.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding STRO
- BVF INC/IL 1.25M sh · $20.17M · Q3 2026
- Affinity Asset Advisors, LLC 1.15M sh · $18.57M · Q3 2026
- Samsara BioCapital, LLC 1.06M sh · $17.12M · Q3 2026
- PERCEPTIVE ADVISORS LLC 970.85K sh · $15.64M · Q3 2026
- Kynam Capital Management, LP 872.56K sh · $14.06M · Q3 2026
- Velan Capital Investment Management LP 510.04K sh · $8.22M · Q3 2026
- Merck & Co., Inc. 272.35K sh · $4.39M · Q3 2026
- Elmind Capital, LP 228.26K sh · $3.68M · Q3 2026
- KVP Capital Advisors, LP 226.57K sh · $3.65M · Q3 2026
More on Seven Fleet Capital Management LP
FAQ
How long has Seven Fleet Capital Management LP held STRO?
Seven Fleet Capital Management LP has disclosed STRO holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Seven Fleet Capital Management LP's current position in STRO?
As of Q3 2026, Seven Fleet Capital Management LP holds 99.89K shares of STRO (SUTRO BIOPHARMA INC), valued at $1.61M, representing 0.31% of its reported portfolio and ranking #38.
Has Seven Fleet Capital Management LP been buying or selling STRO?
In the latest 13F filing (Q3 2026), Seven Fleet Capital Management LP reduced its position in STRO.
Which other funds hold STRO?
Other major institutional holders of STRO include BVF INC/IL, Affinity Asset Advisors, LLC, Samsara BioCapital, LLC, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.